Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 571

1.

Good Practice Chaplaincy: An Exploratory Study Identifying the Appropriate Skills, Attitudes and Practices for the Selection, Training and Utilisation of Chaplains.

Carey LB, Rumbold B.

J Relig Health. 2014 Nov 5. [Epub ahead of print]

PMID:
25371346
[PubMed - as supplied by publisher]
2.

Association of Montevideo units with uterine rupture in women undergoing a trial of labor.

Maggio L, Forbes J, Carey LL, Sangi-Haghpeykar H, Davidson C.

J Reprod Med. 2014 Sep-Oct;59(9-10):464-70.

PMID:
25330688
[PubMed - in process]
3.

Reorganizing Therapy: Changing the Clinical Approach to Upper Limb Recovery Post-Stroke.

Hubbard IJ, Carey LM, Budd TW, Parsons MW.

Occup Ther Int. 2014 Oct 18. doi: 10.1002/oti.1381. [Epub ahead of print]

PMID:
25327458
[PubMed - as supplied by publisher]
4.

A phase II study of medroxyprogesterone acetate in patients with hormone receptor negative metastatic breast cancer: translational breast cancer research consortium trial 007.

Miller KD, Althouse SK, Nabell L, Rugo H, Carey L, Kimmick G, Jones DR, Merino MJ, Steeg PS.

Breast Cancer Res Treat. 2014 Nov;148(1):99-106. doi: 10.1007/s10549-014-3131-3. Epub 2014 Sep 26.

PMID:
25257727
[PubMed - in process]
5.

Making sense of dual HER2-targeting in early breast cancer?

Carey LA, Barry W.

J Natl Cancer Inst. 2014 Sep 15;106(9). pii: dju259. doi: 10.1093/jnci/dju259. Print 2014 Sep. No abstract available.

PMID:
25224563
[PubMed - indexed for MEDLINE]
6.

The Utility of the WHO ICD-10-AM Pastoral Intervention Codings Within Religious, Pastoral and Spiritual Care Research.

Carey LB, Cohen J.

J Relig Health. 2014 Sep 11. [Epub ahead of print]

PMID:
25209684
[PubMed - as supplied by publisher]
7.

Chemotherapy and targeted therapy for women with human epidermal growth factor receptor 2-negative (or unknown) advanced breast cancer: American Society of Clinical Oncology Clinical Practice Guideline.

Partridge AH, Rumble RB, Carey LA, Come SE, Davidson NE, Di Leo A, Gralow J, Hortobagyi GN, Moy B, Yee D, Brundage SB, Danso MA, Wilcox M, Smith IE.

J Clin Oncol. 2014 Oct 10;32(29):3307-29. doi: 10.1200/JCO.2014.56.7479. Epub 2014 Sep 2.

PMID:
25185096
[PubMed - in process]
8.

Non-steroidal anti-inflammatory drug use, hormone receptor status, and breast cancer-specific mortality in the Carolina Breast Cancer Study.

Allott EH, Tse CK, Olshan AF, Carey LA, Moorman PG, Troester MA.

Breast Cancer Res Treat. 2014 Sep;147(2):415-21. doi: 10.1007/s10549-014-3099-z. Epub 2014 Aug 24.

PMID:
25151293
[PubMed - in process]
9.

Religion, Health and Confidentiality: An Exploratory Review of the Role of Chaplains.

Carey LB, Willis MA, Krikheli L, O'Brien A.

J Relig Health. 2014 Aug 23. [Epub ahead of print]

PMID:
25150056
[PubMed - as supplied by publisher]
10.

Age-specific changes in intrinsic breast cancer subtypes: a focus on older women.

Jenkins EO, Deal AM, Anders CK, Prat A, Perou CM, Carey LA, Muss HB.

Oncologist. 2014 Oct;19(10):1076-83. doi: 10.1634/theoncologist.2014-0184. Epub 2014 Aug 20.

PMID:
25142841
[PubMed - in process]
11.

Molecular features and survival outcomes of the intrinsic subtypes within HER2-positive breast cancer.

Prat A, Carey LA, Adamo B, Vidal M, Tabernero J, Cortés J, Parker JS, Perou CM, Baselga J.

J Natl Cancer Inst. 2014 Aug 19;106(8). pii: dju152. doi: 10.1093/jnci/dju152. Print 2014 Aug.

PMID:
25139534
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Predicting response and survival in chemotherapy-treated triple-negative breast cancer.

Prat A, Lluch A, Albanell J, Barry WT, Fan C, Chacón JI, Parker JS, Calvo L, Plazaola A, Arcusa A, Seguí-Palmer MA, Burgues O, Ribelles N, Rodriguez-Lescure A, Guerrero A, Ruiz-Borrego M, Munarriz B, López JA, Adamo B, Cheang MC, Li Y, Hu Z, Gulley ML, Vidal MJ, Pitcher BN, Liu MC, Citron ML, Ellis MJ, Mardis E, Vickery T, Hudis CA, Winer EP, Carey LA, Caballero R, Carrasco E, Martín M, Perou CM, Alba E.

Br J Cancer. 2014 Oct 14;111(8):1532-41. doi: 10.1038/bjc.2014.444. Epub 2014 Aug 7.

PMID:
25101563
[PubMed - in process]
Free PMC Article
13.

Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance).

Sikov WM, Berry DA, Perou CM, Singh B, Cirrincione CT, Tolaney SM, Kuzma CS, Pluard TJ, Somlo G, Port ER, Golshan M, Bellon JR, Collyar D, Hahn OM, Carey LA, Hudis CA, Winer EP.

J Clin Oncol. 2014 Aug 4. pii: JCO.2014.57.0572. [Epub ahead of print]

PMID:
25092775
[PubMed - as supplied by publisher]
14.

TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases.

Anders C, Deal AM, Abramson V, Liu MC, Storniolo AM, Carpenter JT, Puhalla S, Nanda R, Melhem-Bertrandt A, Lin NU, Kelly Marcom P, Van Poznak C, Stearns V, Melisko M, Smith JK, Karginova O, Parker J, Berg J, Winer EP, Peterman A, Prat A, Perou CM, Wolff AC, Carey LA.

Breast Cancer Res Treat. 2014 Aug;146(3):557-66. doi: 10.1007/s10549-014-3039-y. Epub 2014 Jul 8.

PMID:
25001612
[PubMed - in process]
Free PMC Article
15.

In vivo degradation of 14C-labeled porcine dermis biologic scaffold.

Carey LE, Dearth CL, Johnson SA, Londono R, Medberry CJ, Daly KA, Badylak SF.

Biomaterials. 2014 Sep;35(29):8297-304. doi: 10.1016/j.biomaterials.2014.06.015. Epub 2014 Jul 3.

PMID:
24997479
[PubMed - in process]
16.

Circles of care: should community development redefine the practice of palliative care?

Abel J, Walter T, Carey LB, Rosenberg J, Noonan K, Horsfall D, Leonard R, Rumbold B, Morris D.

BMJ Support Palliat Care. 2013 Dec;3(4):383-8. doi: 10.1136/bmjspcare-2012-000359. Epub 2013 Mar 6.

PMID:
24950517
[PubMed - in process]
17.

Prognostic B-cell signatures using mRNA-seq in patients with subtype-specific breast and ovarian cancer.

Iglesia MD, Vincent BG, Parker JS, Hoadley KA, Carey LA, Perou CM, Serody JS.

Clin Cancer Res. 2014 Jul 15;20(14):3818-29. doi: 10.1158/1078-0432.CCR-13-3368. Epub 2014 Jun 10.

PMID:
24916698
[PubMed - in process]
18.

Publication metrics and success on the academic job market.

van Dijk D, Manor O, Carey LB.

Curr Biol. 2014 Jun 2;24(11):R516-7. doi: 10.1016/j.cub.2014.04.039.

PMID:
24892909
[PubMed - in process]
19.

Effect of specific amino acid substitutions in the putative fusion peptide of structural glycoprotein E2 on Classical Swine Fever Virus replication.

Fernández-Sainz IJ, Largo E, Gladue DP, Fletcher P, O'Donnell V, Holinka LG, Carey LB, Lu X, Nieva JL, Borca MV.

Virology. 2014 May;456-457:121-30. doi: 10.1016/j.virol.2014.03.005. Epub 2014 Apr 4.

PMID:
24889231
[PubMed - indexed for MEDLINE]
20.

How low should we go? The search for balance in management of small human epidermal growth factor receptor 2-positive breast cancers.

Reeder-Hayes KE, Carey LA.

J Clin Oncol. 2014 Jul 10;32(20):2122-4. doi: 10.1200/JCO.2014.55.7249. Epub 2014 Jun 2. No abstract available.

PMID:
24888811
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk